CoChat

Polypharmacy- Purpose, Benefits and Limitations

Grover, Douglas, Tom, Michelle, Maguire, Gerald, Stahl, Stephen · 2022 · Current Medicinal Chemistry

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

With what has become increasingly common among nearly all medical specialties, the number of patients who have various comorbid diseases both psychiatrically and mentally challenges the field of psychiatry. As a result, it is not uncommon for physicians to be imposed with treatment decisions regarding polypharmacy, the use of multiple medications to treat different diseases, or even the same illness several times. In recent years, the concept of polypharmacy has been known to have a negative undertone, implying that its use is inappropriate or causes more harm than the potential benefit. Although the use of any medication should involve risk versus benefit discussion, when used with good clinical judgment and pharmacologically sound knowledge, this practice can be potentially life-altering for patients.

Overview

Integrity signals

Registry

Crossref · 10.2174/0929867329666220107153813

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 40 references

Research works printed but not linked: 2

  1. Stahl S.M.; Stahl’s essential psychopharmacology: Neuroscientific basis and practical application 2013
  2. Stahl Morrissette D.; Should high dose or very long-term antipsychotic monotherapy be considered before antipsychotic polypharmacy? Polypharmacy in Psychiatry Practice 2013,107-125

Cited by

See all 7

Metadata

Authors
Grover, D., Tom, M., Maguire, G., & Stahl, S.
Affiliations
University of California, Riverside (US)
Corresponding author
Grover, Douglas
Venue
Current Medicinal Chemistry
Published
2022-10
Volume
29
Issue
35
Pages
5606-5614
ISSN
0929-8673 (ISSN-L)
OpenAlex
W4205166434
Cited by
7
References
40
Citations by year
2026: 2 · 2024: 1 · 2023: 3 · 2022: 1
FWCI
0.71
Type
journal article
Language
en
Open access
closed
Locations
  • Current Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
  • Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
Keywords
polypharmacy, multiple drugs, comorbidities, mental illness, risk-benefit assessment, medication management
MeSH terms
Humans, Polypharmacy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Polypharmacy- Purpose, Benefits and Limitations. https://app.cochat.ai/papers/10.2174/0929867329666220107153813
The paper
Grover, D., Tom, M., Maguire, G., & Stahl, S. (2022). Polypharmacy- Purpose, Benefits and Limitations. Current Medicinal Chemistry. https://doi.org/10.2174/0929867329666220107153813

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.